SG
PFE icon

Stonnington Group’s Pfizer PFE Stock Holding History

Stonnington Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$1.52M Sell
36,685
-16,290
-31% -$704K 0.4% 68
2022
Q4 		$2.52M Sell
52,975
-10,793
-17% -$517K 0.7% 41
2022
Q3 		$2.75M Sell
63,768
-11,891
-16% -$578K 0.78% 32
2022
Q2 		$4.04M Sell
75,659
-1,765
-2% -$89.9K 1.08% 19
2022
Q1 		$4.17M Sell
77,424
-46,028
-37% -$2.39M 1% 27
2021
Q4 		$7M Buy
123,452
+94,763
+330% +$4.7M 1.51% 14
2021
Q3 		$1.22M Buy
28,689
+4,380
+18% +$194K 0.27% 94
2021
Q2 		$954K Sell
24,309
-493
-2% -$19.2K 0.21% 118
2021
Q1 		$984K Buy
+24,802
New +$881K 0.24% 109

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Stonnington Group's PFE Position: Q1 2023 in Review

Stonnington Group reduced its Pfizer (PFE) stake by 31% in Q1 2023, selling an estimated $704K and leaving 36,685 shares worth $1.52M. The position accounts for 0.4% of the portfolio, ranked #68.

Stonnington Group first reported a position in PFE in Q1 2021 and has held it in 9 quarters since. The position peaked at $7M in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Stonnington Group held 36,685 shares of Pfizer worth $1.52M as of Q1 2023.
  • Stonnington Group sold 16,290 Pfizer shares in Q1 2023, an estimated $704K.
  • Pfizer made up 0.4% of Stonnington Group's portfolio in Q1 2023, its #68 holding.
  • Stonnington Group first reported a position in Pfizer in Q1 2021 and has held it in 9 quarters since.
  • Stonnington Group's Pfizer position peaked at $7M in Q4 2021.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.